Company profile
PharmaBiome AG
Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.
- Industry
- Biotechnology Research
- Employees
- 10
- Headquarters
- Schlieren, Zurich
- Founded
- 2015
- LinkedIn followers
- 3,613
- Office locations
- 1
PharmaBiome AG company summary
PharmaBiome AG is a company in the Biotechnology Research industry, headquartered in Schlieren, Zurich, founded in 2015. On LinkedIn the company has around 10 employees and 3,613 followers. Its listed specialties include Microbiome Drug Development, Biotechnology, Microbiome Analysis, Next-Generation LBPs.
What technology does PharmaBiome AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About PharmaBiome AG
PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This holds the promise of becoming a first step into the creation of personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs. PharmaBiome has invested years in developing a biology-based analysis tool that allows for the identification and selection of the metabolic functions needed to restore the gut microbiome to a balanced state. The resulting formulation compounds the over 500 different strains that every person hosts to a minimal consortium of bacteria representing a healthy microbiome. The co-culture of this bacterial mix transforms it into a live biotherapeutic product whose active principle is based on the composition, function, and interactions between the microorganisms. The flexibility and speed of this process are a unique advantage to bring to life effective treatment options. Over the years, it has been recognized with several start-up awards such as Venture Kick, the ETH Spark Award, and the BaseLaunch Accelerator.
Specialties
Where is PharmaBiome AG located?
PharmaBiome AG lists 1 location.
Compare companies similar to PharmaBiome AG
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
PharmaBiome AG pharmabiome.com | Biotechnology Research | 10 | 2015 | Schlieren, Zurich |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about PharmaBiome AG
What does PharmaBiome AG do?
PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This holds the promise of becoming a first step into the creation of personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs. PharmaBiome has invested years in developing a biology-based analysis tool that allows for the identification and selection of the metabolic functions needed to restore the gut microbiome to a balanced state. The resulting formulation compounds the over 500 different strains that every person hosts to a minimal consortium of bacteria representing a healthy microbiome. The co-culture of this bacterial mix transforms it into a live biotherapeutic product whose active principle is based on the composition, function, and interactions between the microorganisms. The flexibility and speed of this process are a unique advantage to bring to life effective treatment options. Over the years, it has been recognized with several start-up awards such as Venture Kick, the ETH Spark Award, and the BaseLaunch Accelerator.
How many employees does PharmaBiome AG have?
PharmaBiome AG has around 10 employees on LinkedIn.
Where is PharmaBiome AG headquartered?
PharmaBiome AG is headquartered in Schlieren, Zurich.
When was PharmaBiome AG founded?
PharmaBiome AG was founded in 2015.
Build a lead list from companies like PharmaBiome AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.